Sabra Health Care REIT (SBRA) Misses Q2 EPS by 2c; Reaffirms
Sabra Health Care REIT (NASDAQ: SBRA) reported Q2 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29.
For the second quarter of 2017, net income attributable to common stockholders, FFO, Normalized FFO, AFFO and Normalized AFFO per diluted common share were $0.27, $0.47, $0.55, $0.55 and $0.53, respectively, compared to $0.53, $0.78, $0.61, $0.75 and $0.58, respectively, for the second quarter of 2016.
For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.
